Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Novel transcript, antisense to NRXN3 (ENSG00000258637)
- Target
- ENSG00000258637
- Molecular classification
- Long non-coding RNA (lncRNA)
01
Overview
This target refers to a non-coding RNA gene, classified as a long non-coding RNA (lncRNA), that is transcribed antisense to the NRXN3 gene locus[1][3]. No protein product is encoded by this transcript, and its specific biological functions, disease associations, and roles as a molecular target are not characterized. NRXN3 itself is a gene encoding a neurexin family member involved in nervous system cell adhesion, but the function of the antisense lncRNA remains unknown[1][5][9]. In summary, ENSG00000258637 does not correspond to a protein-coding gene, receptor, enzyme, or therapeutic target, but is an annotated non-coding RNA of currently uncharacterized function[1][3].
02
Mechanism of action
Not applicable; there are no drugs targeting this lncRNA.
03
Biological functions
Unknown; the biological functions are not characterized for this transcript. As an antisense lncRNA to NRXN3, it may have regulatory roles, but direct evidence is lacking from available results.
04
Disease associations
None established; the disease roles for this specific lncRNA transcript are not documented in current databases. Its relationship to the protein-coding NRXN3 gene, which has roles in neurodevelopment and neuropsychiatric disease, is speculative.
Beyond the preview
Go deeper on Novel transcript, antisense to NRXN3 (ENSG00000258637).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Novel transcript, antisense to NRXN3 (ENSG00000258637).